Skip to Main Content

Paper Details

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.
Therap Adv Gastroenterol
6
2020
47, CD, Crohn's disease, Mucosal Addressin Cell Adhesion Molecule (MAdCAM)-1, VCAM-1, integrin, patients, s, s-47, s-47 integrin, s-ICAM-, s-ICAM-1, s-Intercellular Cell Adhesion Molecule (ICAM)-1, s-MAdCAM-1, s-VCAM-1, soluble (s)-Vascular Cell Adhesion Molecule (VCAM)-1, vedolizumab
Author NameAffiliation
Parambir S DulaiUniversity of California
Nghia H NguyenUniversity of California
Siddharth SinghUniversity of California
William J SandbornUniversity of California
Brigid S BolandUniversity of California
Brigid S BolandUniversity of California
  • 1 - 6

Datasets

Release 1.2